• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Medicin: icke kliniska discipliner
    3. Fysiologi

    Lahita's Systemic Lupus Erythematosus

    AvRobert Lahita

    Inbunden, Engelska, 2021

    2 958 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Systemic lupus erythematosus (SLE), commonly called lupus, is a chronic autoimmune disorder that can affect virtually any organ of the body. In lupus, the body's immune system, which normally functions to protect against foreign invaders, becomes hyperactive, forming antibodies that attack normal tissues and organs, including the skin, joints, kidneys, brain, heart, lungs, and blood. Lupus is characterized by periods of illness, called flares, and periods of wellness or remission.

    Because its symptoms come and go and mimic those of other diseases, lupus is difficult to diagnose. There is no single laboratory test that can definitively prove that a person has the complex illness.

    To date, lupus has no known cause or cure. Early detection and treatment are the key to a better health outcome and can usually lessen the progression and severity of the disease. Anti-inflammatory drugs, antimalarials, and steroids (such as cortisone and others) are often used to treat lupus. Cytotoxic chemotherapies, like those used in the treatment of cancer, are also used to suppress the immune system in lupus patients.

    A new edition of this established and well-regarded reference combines basic science with clinical science to provide a translational medicine model. Systemic Lupus Erythematosus, Sixth Edition, is a useful reference for specialists in the diagnosis and management of patients with SLE, a tool for measurement of clinical activity for pharmaceutical development and basic research of the disease, and a reference work for hospital libraries.

    • Completely updated, revised, and expanded with the most comprehensive and accessible reference on SLE for clinicians and scientists
    • Full-color presentation throughout the book
    • Provides the latest information available on diagnosis and treatment
    • Incorporates an international panel of authors who are experts in their fields, with an emphasis on young, cutting-edge scientists and physicians

    Produktinformation

    • Utgivningsdatum:2021-07-27
    • Mått:216 x 276 x undefined mm
    • Vikt:2 200 g
    • Format:Inbunden
    • Språk:Engelska
    • Antal sidor:730
    • Upplaga:6
    • Förlag:Elsevier Science
    • ISBN:9780128205839

    Utforska kategorier

    • Fysiologi inom Medicin
    • Onkologi inom Medicin
    • Anatomi inom Medicin

    Mer om författaren

    Robert G. Lahita, MD, PhD, is Clinical Professor of Medicine at Hackensack Meridian School of Medicine and Director of the Institute for Autoimmune and Rheumatic Diseases at St. Joseph's Health, Wayne, New Jersey. A Fellow of the American College of Physicians and the Royal College of Physicians, and a Master of the American College of Rheumatology, he serves as Associate Editor of Lupus: An International Journal. His research focuses on the immunopathogenesis of systemic lupus erythematosus, immune endocrinology, and the hormonal regulation of autoimmunity. He has served as editor of Systemic Lupus Erythematosus across multiple editions and as Senior Editor of the Textbook of Autoimmune Diseases.

    Recensioner i media

    "This sixth edition offers up-to-date information pertaining to various aspects of systemic lupus erythematosus (SLE).... The book focuses on updating rheumatology specialists with recent discoveries in genetics, immunology, microbiology, and microbiome, and expands on how these discoveries pertain to the pathogenesis of SLE.... The second part focuses on clinical SLE and later explores the potential of new treatments based on these findings. This book is definitely needed given the significant findings that help to explain SLE. The chapters are well written and meet the objectives of updating specialists about SLE. This book is targeted to specialists in rheumatology given the complexity and detail of each chapter.... Each chapter is well written and supported by up-to-date references.... Diagrams are well visualized and interpreted for readers. Overall, this is an excellent book and very much needed given the recent discoveries. This book is a must-read for rheumatologists." --Joseph S Yusin, MD(VA Greater Los Angeles Healthcare System)

    Innehållsförteckning

    • Part I: Basis of the DiseaseSection A: Genetics and epigenetics1. Major histocompatibility complex and SLE2. Lupus Susceptibility genes3. Epigenetics in systemic lupus erythematosus and the integration of molecular pathwaysSection B: Immunopathogenesis4. Autoantigens, antigenic mimicry, and immune complexes5. B-cell Biology, tolerance and autoantibodies6. T-Cell Biology, tolerance and regulation7. Polymorphonuclear cells8. Metabolic and mitochondrial dysfunction in SLE9. Immunopathogenesis: the role of mucosal and skin microbiota in SLESection C: Disease effectors and modifiers10. Complement and SLE11. Interferons and cytokines in SLE pathogenesis and therapy12. Innate immunity in SLE pathogenesis13. Sex bias in SLESection D: Tissue injury—the Biology14. Mechanisms of tissue injury in lupus nephritis15. The skin16. The brain in SLE: mechanisms and detection of injury and therapeutic strategies17. The role of infections in SLE pathogenesis18. Tissue injurydthe biology: SLE-associated vascular disease and antiphospholipid syndromePart II: Clinical presentation of diseaseSection A: Clinical presentation19. Epidemiology of SLE and related diseases: incidence, prevalence, and mortality20. The clinical presentation of systemic lupus erythematosus and laboratory diagnosis21. Passively acquired lupus in the fetus and neonate22. Systemic lupus erythematosus in children23. Environmental and drug-induced lupus24. Reproductive health25. Monitoring disease activity26. Overlap syndromesSection B: Specific organ involvement and clinical presentation27. Nervous system28. Skin29. Kidney disease30. Cardiovascular disease in lupus31. Pulmonary manifestations of systemic lupus erythematosus32. GI hepatic and nonhepatic diseases33. Musculoskeletal system: articular disease, myositis, and bone metabolism34. Clinical presentation of antiphospholipid syndrome35. Hematology: cytopenias36. Malignancy risk and screeningSection C: Treatment of systemic llupus erythematosus37. Antimalarial drugs (and lupus)38. Glucocorticoids39. Immunosuppressive therapy in SLE40. Pipeline therapies and future drug development41. Challenges of systemic lupus clinical trials